Advances in Tendon and Ligament Tissue Engineering: Materials Perspective.
Traumatic tendon and ligamentous injuries represent significant healthcare and economic challenges for the future. Notably, these injuries are estimated to affect 110 million people in the United States , and incomplete repair is associated with variable disabilities and chronic sequelae [2, 3].
Tendon represents a specialised connective tissue in which collagen type I accounts for ~80% of the net dry weight. In combination with proteoglycans and elastin, collagen permits high mechanical strength in tendons [4, 5]. Furthermore, tendons display a unique structural hierarchy where collagen molecules produce collagen fibrils, which group together to form collagen fibres. The multicomposite tendon units are composed of several collagen fibres, known as tropocollagen (Figure 1) [3, 4, 6].
Ligaments are another form of viscoelastic connective tissue, with a highly organised composition where collagens (types I, III, and V) constitute the bulk. Proteoglycans and chondroitin sulfate are also expressed, allowing the ligament tissue to swell in aqueous environments . In the body, the attachment of tendons and ligaments to bone involves a transition zone with unmineralised and mineralised fibrocartilage [3, 8]. Tendons can further attach to muscles through fascia . Defining the structural organisation of tendons and ligaments has improved understanding of the way these heterogeneous tissues function in synergy .
Surgical repair of tendons and ligaments via primary suture or autologous transfer techniques are considered the gold standard modality of care. However, these solutions are often associated with challenges including reduced mechanical strength due to scar tissue formation, infections, donor site morbidity, and limited availability of autografts . Furthermore, specialised physiotherapy protocols are required to improve the repair-site properties and limit scar tissue formation .
To overcome this clinical issue, additional therapeutic options involving the use of synthetic prosthesis or tissue engineered biomaterial constructs have been investigated in the literature . Ranges of synthetic prosthetic devices have been described as tendon and ligament tissue substitutes. Nonabsorbable and biocompatible polyester polyethylene terephthalate (PET) was investigated as a potential tendon and ligament tissue prosthesis material with suitable mechanical and tissue integrative properties [13, 14]. Other materials like polytetrafluoroethylene (PTFE) were also investigated as ligament tissue substitutes or in tendon augmentation grafts, for their biologically inert and strong mechanical characteristics [15, 16]. However, limitations such as graft failure, poor durability, poor tissue integration, and foreign body synovitis were observed with these materials . Tissue engineering represents an alternative option with potential for proper tissue integration of implants.
Different synthetic or naturally derived materials have been investigated as scaffolds, which permit cell integration and subsequent matrix deposition. Among the naturally derived materials, collagen and chitosan have been extensively investigated for scaffold development due to their optimum biocompatibility and tissue integration potential . Nevertheless, these materials exhibit limitations such as low mechanical strength, batch variability, and difficult processing with latent immunogenicity .
Synthetic materials, including polylactic acid (PLA), polyglycolic acid (PGA), and polylactic-co-glycolic acid (PLGA) have been extensively investigated for tendon and ligament repair . Synthetics exhibit several advantages linked to large-scale manufacturing, limited disease transmission, controlled degradation, and better host tissue integration. There are also limitations associated with synthetic biomaterials; cell integration is challenging without further material treatment, degradation-related products can be cytotoxic, and the materials are mechanically weaker than healthy musculoskeletal tissues [18, 21].
Novel tissue engineering approaches using composite materials have also been described to mimic the complex, nonhomogenous environments in tendons and ligaments. In these composite materials, specialised cells have been combined with biomaterials to produce complex, heterogeneous scaffolds with controlled mechanical properties [1, 9]. This review will present an overview of the different approaches described to address the use of composite scaffolds for tendon and ligament tissue engineering. An in-depth critique of the mechanical properties, cell/ tissue integration, success criteria, and limitations is discussed in detail.
2. Materials and Methodology
Comprehensive literature searches were conducted on the PubMed, Medline, Web of Science, and Google Scholar databases. Various combinations of keywords were used in the search process, including "tendon", "ligament", "tissue", "engineering", "hybrid", "composite", "scaffold", "material", "biomaterial", "graft", and "polymer". Only publications in English were included and there were no restrictions on year of publication since no previous reviews were found covering the use of composite materials in tendon and ligament tissue engineering simultaneously. All relevant manuscripts were accessed and articles that combined tissue engineering approaches for both tendons and ligaments were included. Articles that discussed different tissue engineering approaches of the tendon/ligament to bone interface were also excluded due to the broadness of the topic and the important number of review articles on the subject [8, 22-24].
3. Results and Discussion
3.1. Composite Scaffolds for Tendon and Ligament Tissue Engineering. Tendon injuries present significant healthcare challenges due to slow healing rates, loss of function, and scar tissue formation around trauma sites . In severe cases, tissue engineered scaffolds have been fabricated to replace the lost tissues. These artificial grafts can be composed of natural or synthetic biomaterials . The ideal scaffold in tendon tissue engineering should exhibit specific properties such as controlled degradation rates, appropriate mechanical properties, nonimmunogenicity, and suturability. Additionally, easy mass processing and fabrication, while mimicking the native tissue environment, are desirable .
3.2. Synthetic Composite Materials. One example of materials used for tendon tissue engineering involved the fabrication of composite, heterogeneous scaffolds from polyglycolic acid (PGA), and polylactic acid (PLA) . The outer surface was composed of a knitted scaffold made from a 4:2 mixture of PGA and PLA fibres. Internally, the construct contained longitudinally arranged, unwoven PGA fibres. The whole construct was folded and secured with sutures at each end to produce a cord structure and was tested both in vitro and in vivo. Results showed that the scaffold seeded with adipose-derived stem cells (ADSCs) promoted matrix deposition and the formation of mature collagen fibrils. These scaffolds presented subphysiological mechanical properties. Although the study showed promising results, assessment of tenogenic differentiation of ADSCs was not elaborated.
Another manufacturing technique was proposed by Baker B. M. et al., who investigated the use of coelectrospinning technique of different polymers to yield a composite scaffold with variable degradation techniques . They evaluated the use of PCL fibres as slow absorbing elements, while PLGA (50:50 polylactic/ glycolic acid) or PCL/ PLGA fibres were applied for intermediate degradation rates in a single scaffold. A water-soluble polyethylene oxide (PEO) was as a sacrificial fibre element with fast absorption rates and aimed to increase the scaffold porosity with minimal influence on scaffold integrity. Mechanical assessment of PCL/ PLGA/ PEO constructs showed a maximum stress yield of nearly 3.5 MPa at 0.08% strain. The modulus was around 100 MPa and the yield strain was 0.026. PCL/ PLGAPCL/ PEO scaffolds showed a maximum stress yield of 2 MPa at 0.12% strain. Initial modulus of the material was 25 MPa and dropped to 12.5 MPa after 63-day incubation in culture media. Strain increased from 0.065% to 0.12% after incubation. A 22% mass decrease of the composite scaffold after hydration was caused by the dissolution of the PEO component. However, the mechanical properties change after hydration and dissolution of PEO are worth further explanation.
It has been suggested that woven scaffolds are superior for tissue integration due to their interconnected porous structures. Nevertheless, they require challenging cell seeding techniques and complex cell delivery systems [4, 5]. Sahoo S. et al. investigated the use of woven scaffolds made from PLGA or PLLA . Both f scaffolds were coated with PCL, PLGA nanofiber, or collagen type I to yield composite scaffolds and were seeded with porcine bone marrow-derived MSCs. Some collagen-coated scaffolds were seeded with human dermal fibroblasts to test cell seeding and integration efficiency. Results showed that PLLA-based woven scaffolds performed inferiorly in terms of cell attachment. This was linked to the hydrophobic nature of the PLLA material. Furthermore, PCL coating of both types of knitted scaffolds was associated with higher mechanical strength but reduced cell attachment. This was also linked to greater hydrophobicity in PCL than in the other polymers.
As mechanical strength is particularly important, an approach using PLA with graphene nanoplatelets (GNP) and PLA with carboxyl functionalized carbon nanotubes (CNT-COOH) has been proposed by Pinto et al. [25, 26]. In vitro assessment of the composite was nontoxic to human fibroblasts. In vivo assessment using mouse model did not show any toxicity or local or systemic inflammatory response. The addition of nanofillers mentioned enhanced the mechanical properties of PLA polymer films reaching Young's modulus of 4.86 [+ or -] 0.47 GPa for CNT-COOH scaffolds and 4.92 [+ or -] 0.15 GPa for GNP scaffold groups. The tensile strength however was mostly enhanced in the PLA/ CNT-COOH scaffolds reaching up to 72.22 [+ or -] 1.52MPa. The authors did not investigate, however, the effect of in vivo implantation on the associated mechanical properties mimicking real clinical settings.
3.3. Biological Composite Scaffolds. Collagen type I composite scaffold was also investigated to incorporate resilin-like protein. Resilin is an arthropods protein with elastic and highly stretchable structure. Sanami, M., et al.  investigated the fabrication of such composite. The scaffold was made through extrusion process of composite solution containing Collagen and Resilin at different concentration into polyethylene glycol buffer. Fibres were subsequently cross-linked using 4-arm poly(ethylene glycol) ether tetrasuccinimidyl glutarate solution. Mechanical assessment showed that resilin in non-cross-linked collagen scaffold significantly reduced stress at break and Young's modulus values, while significantly increasing break strain. Cross-linked collagen/resilin scaffold showed significant increase in stress and strain values and a significantly decreased Young's modulus values. This shows an interesting effect of resilin exhibiting its natural properties. In vitro, the scaffold produced supported 100% fibroblast proliferation and alignment compared to 80% in collagenfibre control.
Scaffolds made from collagen and glycosaminoglycan (GAG) were recognised for their role in supporting cellular proliferation and differentiation. However, this type of scaffold lacks the mechanical characteristics required for tendon tissue engineering applications. Caliari et al., 2011, have proposed the concept of developing composite materials in a core-shell fashion with the necessary mechanical properties . The group fabricated scaffolds composed of highly porous, aligned isotropic GAG cores surrounded by strong, high density isotropic GAG membranes. The core-shell design was proposed to increase the mechanical strength of the scaffolds. The material was fabricated using an evaporation technique to create membranes and freeze-drying to incorporate the core within the membrane shell. Dehydrothermal (DTH) cross-linking was used to increase material integration, as well as the mechanical properties. In vitro assessment using horse-derived tenocytes demonstrated good cell attachment, proliferation, and cell viability up to 14 days after seeding. Scaffolds exhibited high porosity and appropriate mechanical properties depending on the membrane thickness. Several factors however that need further investigation like cellular functional assessment (e.g., protein expression), nature and content of collagen after cell seeding, and the mechanical properties of the scaffold at different states (e.g., wet versus dry).
Chitosan is a naturally derived polysaccharide with excellent potential for tissue engineering applications. Due to the biocompatible and cell adhesive properties of chitosan, the polysaccharide has been investigated for tendon tissue regeneration [9-11]. In one example, composite scaffolds made from chitosan and alginates were produced through a spinning/coagulation technique to yield an alginate-0.1% chitosan scaffold. Alginate is an anionic polysaccharide with calcium chain in which the integration of chitosan improves its biocompatibility and cell adhesive potential and decreases its degradation rate. In vitro assessment using rabbit patellar tendon fibroblasts showed that alginate-0.1% chitosan scaffolds had significantly higher cell adhesion and matrix deposition compared to alginate-only and polyglactin 910 controls. The alginate-0.1% chitosan material was evaluated mechanically and exhibited lower tensile strength and strain at failure than the polyglactin group . Chitosan was also fabricated with hyaluronic acid followed by wet spinning and hybridisation to increase the mechanical properties of the construct. Different hyaluronic acid concentrations were investigated and showed that the combination of chitosan with 0.1% hyaluronic acid showed the best cell attachment. The final composite constructs were sterilised using ethylene oxide gas prior to in vitro evaluation with rabbit patellar fibroblasts. Mechanical properties of the materials were reduced within the first 2 hours after seeding but the consequent modulus was maintained for 28 days of culture. Cell proliferation quantification using DNA content analysis showed significant improvement in chitosan-0.1% hyaluronic acid composites compared to other chitosan-based scaffolds. To determine the clinical potential of the composite scaffolds, authors assessed the chitosan-0.1% hyaluronic acid composites in vivo by treating rabbit rotator cuff injuries with cell-seeded scaffolds . The scaffolds were cultured with rabbit patellar tendon fibroblasts for 4 weeks prior to implantation. Additionally, authors tested the potential for ligament tissue engineering using a rabbit medial collateral ligament injury model. They used scaffolds seeded with fibroblasts adapted from rabbits Achilles tendon for 2 weeks prior to implantation. For the tendon model, results indicated collagen deposition in cell-seeded scaffolds with significant improvement in the mechanical properties from 4 to 12 weeks after implantation. For the ligament-engineering model, authors showed a lack of tissue integration with the bony tunnel attachment with 60% recovery in failure load compared to healthy ligament. Additional research on the chitosan-hyaluronic acid scaffolds has aimed to understand the effects of mechanical stimulation on fibroblasts response . It was found that the application of 90-degree rotations and 5% stretch at 0.5 Hz was associated with increased expression of fibromodulin, and collagens I and III. No further assessment of the overall mechanical influence of the cultured scaffolds under dynamic conditions was made.
Additionally, composite scaffolds made from extruded, cross-linked bovine type I collagen and chondroitin-6-sulfate were fabricated . The collagen-based constructs underwent a series of cross-linking steps using carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and N-hydroxysuccinimide (NHS). Cross-linking was combined with freeze-drying to incorporate a porous chondroitin-6sulfate. The final constructs had open and interconnected porosity with an average pore size of 100 [micro]m and axially aligned collagen fibres. Mechanical assessment showed that the cross-linked composite scaffolds could withstand 61.94 [+ or -] 15.54 N, compared to 11.75 [+ or -] 2.62 N without cross-linking. The maximum strain was shown to be 30.17 [+ or -] 7.17% with cross-linked fibres, while it was 15.40 [+ or -] 3.22% without. Composites with cross-linked fibres presented a tensile strength of 1.55 [+ or -] 0.30 MPa compared to 0.24 [+ or -] 0.08 MPa for non-cross-linked fibres. It is important to mention that scaffold porosity is inversely related to mechanical strength and further studies are required to evaluate the cell response of such construct for application in tendon and ligament tissue engineering.
Gelatin was also utilised to fabricate a composite scaffold for tendon tissue engineering applications. Coelectrospinning of aligned poly-[epsilon]-caprolactone (PCL) and methacrylated gelatin (mGLT) followed by photo-cross-linking was used in the fabrication process . Scaffold films were first produced and then were seeded with ADSC, after which photo-cross-linking of 5 layers using UV radiation was made to produce a multilayered scaffold mimicking the natural tendon structure. In vitro assessment showed biocompatibility of produced composite in which ADSCs were oriented along the longitudinal access of aligned fibre construct and expressed tendon-related markers (scleraxis and tenascin-C) after being stimulated with TGF[beta]-3. Mechanical assessment of cell-seeded cross-linked scaffolds however was far inferior for potential clinical application (details in Table 1).
Other groups have combined collagen type I with silk to improve scaffold properties for tendon applications . Sericin protein was extracted from silk fibres produced by Bombyx mori, and mixed with collagen solution to fill the gaps in the silk fibre net. Furthermore, adherence and mechanical strength were increased though DTH crosslinking. Mesenchymal stem cells derived from human embryonic stem cells (hEC-MSCs) were used in in vitro and in vivo models and showed that the mechanicallyloaded knitted silk/ collagen microsponge scaffolds can induce tenogenic differentiation in mesenchymal stem cells and support tendon regeneration up to 360 days after implantation (Table 1).
In an additional study, the same composite scaffolds were tested with the supplementation of recombinant human stromal cell-derived factor-1 alpha (rhSDF-1 alpha), to the collagen type I sponges . SDF-1 is a chemokine that promotes cell recruitment and enhances tissue regeneration. In a murine Achilles tendon model, the authors showed that this approach permits higher expression of collagen one week after implantation, indicating an accelerated onset of tendon healing. Further, the mechanical properties were marginally higher than in scaffolds without rhSDF-1 alpha treatment.
In order to improve the mechanical properties and tendon regeneration, Chen X. et al. utilised the same composite scaffolds with hEC-MSCs . Cells were genetically engineered to overexpress the Scleraxis (SCX) gene. SCX is a transcription factor identified for its role as a tenocyte marker and upstream regulator of tendon-related genes. In vitro and in vivo results showed enhanced tendon regeneration and better quality neotendon formation, compared to the previous studies with the same scaffolds. Importantly, there was less osteogenic, chondrogenic, and adipogenic differentiation of the SCX-hEC-MSCs compared to nongenetically modified MSCs. Mechanical properties in a murine Achilles tendon eight weeks after implantation were inferior to native tendon tissue. This research highlights that scaffold properties are important for tendon tissue engineering, but factors like cell-types used can influence mechanical and histological results.
3.4. Synthetic and Biological Composite Scaffolds. Others have also focused on incorporating PLGA with silk derived materials for tendon tissue engineering applications . A composite scaffold comprised degummed silk microfibers coated electrospun PLGA. The authors degummed silk fibres to achieve a more efficient sericin removal. This resulted in smoother fibre surfaces and preserved the general mechanical properties of the silk. In vitro studies using rabbit bone marrow-derived MSCs revealed good cell viability depending on the seeding technique applied (single or dual surface seeding) and whether scaffolds had a flat or rolled/ cylindrical morphology. Rolled structures had lower cell proliferation compared to the other constructs but, overall, the electrospun PLGA polymer provided a large surface area for cell proliferation. To increase tenocyte differentiation of bone marrow-derived MSCs, authors reported a modified protocol in which the scaffold has a 1-week release of basic fibroblast growth factor (bFGF) . bFGF was blended with PLGA and bovine serum albumin prior to electrospinning with knitted silk fibres. Results showed that incorporating bFGF was associated with upregulation of tenogenic markers during MSC differentiation. Collagen expression was also increased, and this contributed to improved mechanical properties of the scaffold. The combined effect of growth factor incorporation together with dynamic culturing conditions would be of interest for its effect over MSC differentiation and overall construct incorporation.
Sharifi-Aghdam M. et al.  have investigated a composite scaffold consisting of knitted silk coated with electrospun collagen-I/polyurethane nanofibres. The main aim of this approach was to incorporate a polyurethane polymer layer to increase the attachment of collagen to silk fibres. In vitro testing using seeded human fibroblast showed that composite scaffold maintained adequate cellular metabolic activity. Assessment of mechanical properties showed an ultimate stress profile reaching 13.5 [+ or -] 1.5MPa and Young's modulus of 21.7 [+ or -] 4MPa. However, further assessment of seeded constructs for their biocompatibility and cell function was not investigated.
Investigative work showed the incorporation of silk with nanofibres derived either from Polycaprolactone (PCL) or Poly(3-hydroxybutyrate) (P3HB) . The composite scaffold was fabricated through electrospinning process of different polymer material over twisted silk fibroin fibres. The main aim of this approach was to incorporate nanofibrous structures onto the composite scaffold to increase the surface to volume ratio and therefore increase cellular attachment. Authors showed a composite scaffold with no toxic effect of seeded fibroblasts with good cellular viability up to day 3 after seeding. Mechanical assessment of fabricated construct showed a maximum load of 97.6 [+ or -] 11.4 N for silk fibroin/P3HB and 110.5 [+ or -] 6.6 N for silk fibroin/PCL with no statistical difference in between. Authors, however, did not further investigate the effect of cellular functions or matrix production or the effect of cell seeding on associated mechanical properties.
Others have focused on the modification of silk to produce scaffolds for tendon regeneration . Degummed silk fibroin meshes were integrated with electrospun aligned silk fibroin cores . In vitro assessment with rabbit MSCs investigated the effects of aligned fabrication techniques, compared to random fabrication, under static and dynamic culture conditions. Results showed that the effects of mechanical stimulation on MSCs was intensified during culture on aligned silk fibroin scaffolds. The dynamic effect was applied in both translational and rotational movement to mimic in vivo environment. This enhanced cellular proliferation and remodelling, with an overall improvement in mechanical properties. Apart from the material used, presence of the aligned scaffold core was proven to be essential for these positive effects when compared to the same scaffolds without alignment. Several authors have showed a similar effect when topography was introduced to the surface of a polymeric scaffold with improvement in cellular alignment and collagen content as well as the expression of different tendon-related extracellular matrix proteins [43, 50].
Elsewhere, collagen has been combined with various polymers through a range of manufacturing techniques to simulate the heterogeneous nature of tendon tissues. Collagen type I was electrospun with synthetic poly(L-lactideco-caprolactone) at a 10:90 ratio, respectively . Fibres were twisted into nanoyarn to produce 150 [micro]m thick scaffolds. Scaffolds aligned randomly or in nanofibers were tested for porosity, surface morphology, and adhesion of tenocytes. Results showed improved cell proliferation in nanoyarn scaffolds, but with poor mechanical properties not useful for future clinical applicability.
In a follow-up study, tendon-derived stem cells (TDSCs) were harvested from rabbit patellar tendons and seeded onto the fibrous scaffolds . In vitro and in vivo assessment under static and dynamic conditions revealed that the composite scaffolds seeded with TDSCs were a promising means for neotendon formation. Furthermore, mechanical dynamic stimulation of the cell-seeded constructs could significantly promote tendon regeneration compared to static culture conditions.
Sensini A. et al. have investigated an electrospun bundled scaffold containing PLA and collagen type I . This scaffold had sufficient mechanical properties with blends containing PLA/collagen 75:25 reaching a Young's modulus of 98.6 [+ or -] 12.4 MPa as spun bundles and 205.1 [+ or -] 73.0 MPa after 14 days of immersion in PBS. Maximum stress was 14.2 [+ or -] 0.7 MPa as spun bundles and 6.8 [+ or -] 0.6 MPa after 14 days in PBS immersion. Tenocytes were metabolically active with good cellular alignment more on blends containing PLA/collagen 50:50 ratio.
Collagen type I has been integrated also with other composite synthetic polymers blends. Polycaprolactone (PCL)/ collagen and poly L-lactide (PLLA)/collagen were evaluated as potential composite materials for tendon-muscle junction tissue engineering . Triphasic scaffolds were fabricated with regions primarily composed of PCL/collagen in one part, PLLA/collagen on the other part, and a mixture of both composites in the middle. All constructs had good biodegradability and biocompatibility. PCL supported myoblast growth due to its low stiffness profile and the higher stiffness of PLLA encouraged fibroblast proliferation. Scaffolds were manufactured using electrospinning technique combined with glutaraldehyde cross-linking and collagen to increase mechanical strength and cell attachment, respectively. In vitro, scaffolds presented good cell integration, viability, and formation of myotubes as those found in tendon-muscle junctions in vivo. Aligned collagen scaffolds were produced with surface cover having polydioxanone (PDS) nanoplates . Assessment in rabbit Achilles tendon demonstrated the same biocompatibility as the previously tested electrospun collagen scaffolds. Further detailed assessment of the composite with and without PDS showed significant improvement in water uptake and release. Histological evaluation showed good tenocyte alignment, neotendon formation, and an initial increase in the inflammatory cell response. The addition of PDS sheets resulted in decreased peritendinous adhesions with higher numbers of mature tenocytes and increased collagen fibril alignment. Improved mechanical properties of the construct were also observed compared to scaffolds made of collagen fibres only [32, 50].
PLLA was also utilised to fabricate a composite scaffold in which electrospinning process was used to form an aligned nanofibres that was later on cross-linked to chitosan-collagen hydrogel mimicking the extracellular matrix of native tendons . The scaffold was rolled and coated on the outer surface with alginate gel aiming to produce an antiadhesion layer around the construct. The scaffold supported cellular alignment and proliferation of tenocytes with no toxic effect. Additionally, adsorption tests showed significantly less attached proteins on the coated surface compared to the noncoated one. Mechanical assessment of produced scaffold showed no effect of coating process on tensile strength of produced scaffold with an effect on the layer number having a value around 2 MPa for 2-layer coated and uncoated scaffolds whereas it was around 6 MPa for uncoated and 4 MPa for coated 3-layer scaffolds. The degradation profile of the scaffold was also investigated and showed that scaffolds maintained 50% of their substance at 21 days after incubation with PBS containing [10.sup.4] units/ml lysozyme solution.
E.C. Green et al.  investigated the fabrication of collagen-I/nanocarbon fibres composite scaffold for potential tendon tissue engineering application. Fibres were made through gel-spinning process with the use of a filling load of 0.5 and 5 wt%. This was followed by fibre elongation at a strain rate of 0.02 mm/s and subsequent glutaraldehyde (GA) crosslinking. Material characterization showed a yielded fibre construct similar to native tendon collagen with enhanced mechanical properties.
3.5. Similarities and Dissimilarities between Tendons and Ligaments. Tendons and ligaments have similar structures with different fundamental properties and functions. Tendons are fibrous inelastic structures that connect muscles to bones within joints while ligaments are fibrous but flexible structures important for supporting bone and cartilage. On a structural level, both connective tissues are dense with variable cellular and proteomic elements. Mechanical analysis of human tendons and ligaments showed that the maximum tensile strength ranges from 4.4 to 660 MPa depending on different locations [55, 56]. The maximum strain of these connective tissues was shown to range between 18 and 30%. Young's modulus was shown to range between 0.2 and 1.5 GPa [57, 58]. Structurally, tendons are predominantly composed of a collagen type I matrix containing tenocytes and tenoblasts. In contrast, ligaments contain glycosaminoglycan and lower levels of collagen compared to tendon tissue, with fibroblasts being the main cellular element (Figure 2) [59, 60]. Kharaz Y. et al. compared the extracellular matrix composition of both, natural and tissue engineered, tendons and ligaments . Results showed that, although tissue engineered constructs share the same composition with the native tissue in variable proportions, fundamental differences exist. Specific proteins, such as asporin and tenomodulin, were limited to tendons, while versican, proteoglycan 4, and SOD3 were ligament-specific (Figure 1). Identifying differences in structural protein expression indicates that tissue engineering approaches should aim to replicate these distinctions at the proteomic level. To date, this has not always been the case, and the terms tendon and ligament are often used interchangeably in the literature. This is predominantly because the two connective tissues exhibit similar functional and mechanical properties . An important concept to remember is that cell source is fundamental in dictating the type of the matrix produced . This highlights the intrinsic cell memory that is different between tendon and ligament. In order to tissue engineer these specific tissues, it is important to consider their functional differences so that biomimicry can be achieved. This will eventually help in enhancing integration and function to be restored when used to replace injured tendon or ligaments. From this, it is clear that although the two tissues share several features, a difference exist.
4. Conclusion and Future Directions
This review summarises the current strategies based on composite biomaterials for tendon and ligaments tissue engineering. This approach represents a way to address the heterogeneous nature shared between tendon and ligaments. Although both structures share similar mechanical properties, their constituting cell-types and extracellular matrix compositions are different. Currently, for tendon tissue engineering, several challenges need to be addressed. First, the necessity for a single standard evaluation identifying the mechanical requirements for successful tendon regeneration is lacking. Crucially, this should incorporate various forms of mechanical assessment (including strain and rotation) with different tissue engineering approaches to mimic the natural environment. This is difficult to achieve and implement because of the heterogeneous nature of tendons. The second challenge is to address and control the response of the surrounding tissue to the implanted scaffold. To date, this has been limited to observation of the intrinsic healing response during in vivo applications. Additionally, most of the studies investigating the use of composite materials for tendon and ligament tissue engineering utilise small animals like rabbits rather than larger models like sheep or horses . Such limitations are based on significant weight and mechanical-related difference between in vivo models and native human tissues. Furthermore, the ability to fix the produced construct in situ (with suture, anchors) and shelf life availability should be considered whenever a model is being tested. In fact the interface scaffold-tendon or scaffold-bone is the place at risk of rupture after implantation rather the scaffolds itself.
The described challenges constitute a potential issue for future clinical application of tissue engineered tendon and ligament solutions. Further research is required on the roles of composite materials in order to mimic the appropriate structural, mechanical, and functional characteristics of tendon and ligaments. While synthetic materials are being used currently in clinical practice for tendon and ligament repairs, it will be essential to mechanically match their properties to native tissue. To mimic the mechanical properties of tendon is particularly important as it would allow faster physiotherapy and therefor reduce scar tissue formation which can evolve to articular stiffness. Moreover, this will enhance integration and healing at injury site. The use of certain growth factors such as basic fibroblast growth factor (bFGF)  can also be employed during surgery to enhance tissue integration. However this requires a strict control and regulated environment. Since advanced composite materials can be tailored to match different mechanical properties of native tissue, they can be incorporated with growth factors and employed with and without cells, providing large number of possibilities for their clinical use based on site and extent of injuries.
Conflicts of Interest
None of the authors have any commercial associations or financial relationships that would create a conflicts of interest with the work presented in this article.
This study was funded by Royal Free Charity (Award no. 167275).
 A. P. Breidenbach, S. D. Gilday, A. L. Lalley et al., "Functional tissue engineering of tendon: Establishing biological success criteria for improving tendon repair," Journal of Biomechanics, vol. 47, no. 9, pp. 1941-1948, 2014.
 U. G. Longo, G. Garau, V. Denaro, and N. Maffulli, "Surgical management of tendinopathy of biceps femoris tendon in athletes," Disability and Rehabilitation, vol. 30, no. 20-22, pp. 1602-1607, 2008.
 C.-F. Liu, L. Aschbacher-Smith, N. J. Barthelery, N. Dyment, D. Butler, and C. Wylie, "What we should know before using tissue engineering techniques to repair injured tendons: a developmental biology perspective," Tissue Engineering Part B: Reviews, vol. 17, no. 3, pp. 165-176, 2011.
 J. H.-C. Wang, Q. Guo, and B. Li, "Tendon biomechanics and mechanobiology--a minireview of basic concepts and recent advancements," Journal of Hand Therapy, vol. 25, no. 2, pp. 133-141, 2012.
 T. W. Lin, L. Cardenas, and L. J. Soslowsky, "Biomechanics of tendon injury and repair," Journal of Biomechanics, vol. 37, no. 6, pp. 865-877, 2004.
 J. Kastelic, A. Galeski, and E. Baer, "The multicomposite structure of tendon," Connective Tissue Research, vol. 6, no. 1, pp. 11-23, 1978.
 J. W. Freeman, M. D. Woods, D. A. Cromer et al., "Evaluation of a hydrogel-fiber composite for ACL tissue engineering," Journal of Biomechanics, vol. 44, no. 4, pp. 694-699, 2011.
 H. H. Lu and S. Thomopoulos, "Functional attachment of soft tissues to bone: Development, healing, and tissue engineering," Annual Review of Biomedical Engineering, vol. 15, pp. 201-226, 2013.
 K. Atesok, M. N. Doral, J. Karlsson et al., "Multilayer scaffolds in orthopaedic tissue engineering," Knee Surgery, Sports Traumatology, Arthroscopy, pp. 1-9, 2014.
 Z. A. Glass, N. R. Schiele, and C. K. Kuo, "Informing tendon tissue engineering with embryonic development," Journal of Biomechanics, vol. 47, no. 9, pp. 1964-1968, 2014.
 V. A. Tsiampa, I. Ignatiadis, A. Papalois, P. Givissis, A. Christodoulou, and J. Friden, "Structural and mechanical integrity of tendon-to-tendon attachments used in upper limb tendon transfer surgery," Journal of Plastic Surgery and Hand Surgery, vol. 46, no. 3-4, pp. 262-266, 2012.
 M. T. Rodrigues, R. L. Reis, and M. E. Gomes, "Engineering tendon and ligament tissues: Present developments towards successful clinical products," Journal of Tissue Engineering and Regenerative Medicine, vol. 7, no. 9, pp. 673-686, 2013.
 A. Melvin, A. Litsky, J. Mayerson, D. Witte, D. Melvin, and N. Juncosa-Melvin, "An artificial tendon with durable muscle interface," Journal of Orthopaedic Research, vol. 28, no. 2, pp. 218-224, 2010.
 K. Gao, S. Chen, L. Wang et al., "Anterior cruciate ligament reconstruction with LARS artificial ligament: a multicenter study with 3-to 5-year follow-up," Arthroscopy: The Journal of Arthroscopic & Related Surgery, vol. 26, no. 4, pp. 515-523, 2010 (Chinese).
 L. E. Paulos, T. D. Rosenberg, S. R. Grewe, D. S. Tearse, and C. L. Beck, "The GORE-TEX anterior cruciate ligament prosthesis: A long-term followup," The American Journal of Sports Medicine, vol. 20, no. 3, pp. 246-252, 1992.
 U. G. Longo, A. Lamberti, N. Maffulli, and V. Denaro, "Tendon augmentation grafts: a systematic review," British Medical Bulletin, vol. 94, no. 1, pp. 165-188, 2010.
 C. M. Glezos, A. Waller, H. E. Bourke, L. J. Salmon, and L. A. Pinczewski, "Disabling synovitis associated with lars artificial ligament use in anterior cruciate ligament reconstruction: A case report," The American Journal of Sports Medicine, vol. 40, no. 5, pp. 1167-1171, 2012.
 Y. Liu, H. S. Ramanath, and D.-A. Wang, "Tendon tissue engineering using scaffold enhancing strategies," Trends in Biotechnology, vol. 26, no. 4, pp. 201-209, 2008.
 A. K. Lynn, I. V. Yannas, and W. Bonfield, "Antigenicity and immunogenicity of collagen," Journal of Biomedical Materials Research PartB: Applied Biomaterials, vol. 71, no. 2, pp. 343-354, 2004.
 H. W. Ouyang, J. C. H. Goh, A. Thambyah, S. H. Teoh, and E. H. Lee, "Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit achilles tendon," Tissue Engineering Part A, vol. 9, no. 3, pp. 431-439, 2003.
 M. G. Galvez, C. Crowe, S. Farnebo, and J. Chang, "Tissue engineering in flexor tendon surgery: Current state and future advances," Journal of Hand Surgery (European Volume), vol. 39, no. 1, pp. 71-78, 2014.
 P Y. Mengsteab, L. S. Nair, and C. T. Laurencin, "The past, present and future of ligament regenerative engineering," Journal of Regenerative Medicine, vol. 11, no. 8, pp. 871-881, 2016.
 L. M. Cross, A. Thakur, N. A. Jalili, M. Detamore, and A. K. Gaharwar, "Nanoengineered biomaterials for repair and regeneration of orthopedic tissue interfaces," Acta Biomaterialia, vol. 42, pp. 2-17, 2016.
 S. Font Tellado, E. R. Balmayor, and M. Van Griensven, "Strategiesto engineertendon/ligament-to-boneinterface: Biomaterials, cells and growth factors," Advanced Drug Delivery Reviews, vol. 94, pp. 126-140, 2015.
 V. Correia Pinto, R. Costa-Almeida, I. Rodrigues, L. Guardao, R. Soares, and R. Miranda Guedes, "Exploring the in vitro and in vivo compatibility of PLA, PLA/GNP and PLA/CNTCOOH biodegradable nanocomposites: Prospects for tendon and ligament applications," Journal of Biomedical Materials Research Part A, vol. 105, no. 8, pp. 2182-2190, 2017
 V. C. Pinto, T. Ramos, A. S. F. Alves et al., "Dispersion and failure analysis of PLA, PLA/GNP and PLA/CNT-COOH biodegradable nanocomposites by SEM and DIC inspection," Engineering Failure Analysis, vol. 71, pp. 63-71, 2017.
 M. Sanami, Z. Shtein, I. Sweeney et al., "Biophysical and biological characterisation of collagen/resilin-like protein composite fibres," Biomedical Materials, vol. 10, no. 6, 2015.
 B. M. Baker, N. L. Nerurkar, J. A. Burdick, D. M. Elliott, and R. L. Mauck, "Fabrication and modeling of dynamic multipolymer nanofibrous scaffolds," Journal of Biomechanical Engineering, vol. 131, no. 10, Article ID 101012-1, 2009.
 S. Sahoo, J. G. Cho-Hong, and T. Siew-Lok, "Development of hybrid polymer scaffolds for potential applications in ligament and tendon tissue engineering," Biomedical Materials, vol. 2, no. 3, pp. 169-173, 2007.
 S. R. Caliari, M. A. Ramirez, and B. A. C. Harley, "The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering," Biomaterials, vol. 32, no. 34, pp. 8990-8998, 2011.
 T. Majima, T. Irie, N. Sawaguchi et al., "Chitosan-based hyaluronan hybrid polymer fibre scaffold for ligament and tendon tissue engineering," Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, vol. 221, no. 5, pp. 537-546, 2007.
 A. Oryan, A. Moshiri, A. M. Parizi, and N. Maffulli, "Implantation of a novel biologic and hybridized tissue engineered bioimplant in large tendon defect: An in vivo investigation," Tissue Engineering Part: A, vol. 20, no. 3-4, pp. 447-465, 2014.
 T. Majima, T. Funakosi, N. Iwasaki et al., "Alginate and chitosan polyion complex hybrid fibers for scaffolds in ligament and tendon tissue engineering," Journal of Orthopaedic Science, vol. 10, no. 3, pp. 302-307, 2005.
 G. Yang, H. Lin, B. B. Rothrauff, S. Yu, and R. S. Tuan, "Multilayered polycaprolactone/gelatin fiber-hydrogel composite for tendon tissue engineering," Acta Biomaterialia, vol. 35, pp. 68-76, 2016.
 N. Sawaguchi, T. Majima, T. Funakoshi et al., "Effect of cyclic three-dimensional strain on cell proliferation and collagen synthesis of fibroblast-seeded chitosan-hyaluronan hybrid polymer fiber," Journal of Orthopaedic Science, vol. 15, no. 4, pp. 569-577, 2010.
 J. H. Shepherd, S. Ghose, S. J. Kew, A. Moavenian, S. M. Best, and R. E. Cameron, "Effect of fiber crosslinking on collagenfiber reinforced collagen-chondroitin-6-sulfate materials for regenerating load-bearing soft tissues," Journal of Biomedical Materials Research Part A, vol. 101, no. 1, pp. 176-184, 2013.
 J. L. Chen, Z. Yin, W. L. Shen et al., "Efficacy of hESC-MSCs in knitted silk-collagen scaffold for tendon tissue engineering and their roles," Biomaterials, vol. 31, no. 36, pp. 9438-9451, 2010.
 W. Shen, X. Chen, J. Chen et al., "The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration," Biomaterials, vol. 31, no. 28, pp. 7239-7249, 2010.
 X. Chen, Z. Yin, and J.-L. Chen, "Scleraxis-overexpressed human embryonic stem cell-derived mesenchymal stem cells for tendon tissue engineering with knitted silk-collagen scaffold," Tissue Engineering Part A, vol. 20, no. 11-12, pp. 1583-1592, 2014.
 S. Sahoo, S. Lok Toh, and J. C. Hong Goh, "PLGA nanofibercoated silk microfibrous scaffold for connective tissue engineering," Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 95, no. 1, pp. 19-28, 2010.
 E. Naghashzargar, S. Fare, V. Catto et al., "Nano/micro hybrid scaffold of PCL or P3Hb nanofibers combined with silk fibroin for tendon and ligament tissue engineering," Journal of Applied Biomaterials and Functional Materials, vol. 13, no. 2, pp. e156-e168, 2015.
 T. K. H. Teh, S.-L. Toh, and J. C. H. Goh, "Aligned fibrous scaffolds for enhanced mechanoresponse and tenogenesis of mesenchymal stem cells," Tissue Engineering Part A, vol. 19, no. 11-12, pp. 1360-1372, 2013.
 F. Alshomer, C. Chaves, T. Serra, I. Ahmed, and D. M. Kalaskar, "Micropatterning of nanocomposite polymer scaffolds using sacrificial phosphate glass fibers for tendon tissue engineering applications," Nanomedicine: Nanotechnology, Biology and Medicine, vol. 13, no. 3, pp. 1267-1277, 2017
 D. Deng, W. Wang, B. Wang et al., "Repair of Achilles tendon defect with autologous ASCs engineered tendon in a rabbit model," Biomaterials, vol. 35, no. 31, pp. 8801-8809, 2014.
 S. Sahoo, S. L. Toh, and J. C. H. Goh, "A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells," Biomaterials, vol. 31, no. 11, pp. 2990-2998, 2010.
 M. Sharifi-Aghdam, R. Faridi-Majidi, M. A. Derakhshan, A. Chegeni, and M. Azami, "Preparation of collagen/polyurethane/knitted silk as a composite scaffold for tendon tissue engineering," Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, vol. 231, no. 7, pp. 652-662, 2017.
 Y. Xu, J. Wu, H. Wang et al., "Fabrication of electrospun poly (L-lactide-co-[epsilon]-caprolactone)/collagen nanoyarn network as a novel, three-dimensional, macroporous, aligned scaffold for tendon tissue engineering," Tissue Engineering Part C: Methods, vol. 19, no. 12, pp. 925-936, 2013.
 Y. Xu, S. Dong, Q. Zhou et al., "The effect of mechanical stimulation on the maturation of TDSCs-poly(L-lactide-coe-caprolactone)/collagen scaffold constructs for tendon tissue engineering," Biomaterials, vol. 35, no. 9, pp. 2760-2772, 2014.
 J. T. Shearn, K. R. C. Kinneberg, N. A. Dyment et al., "Tendon tissue engineering: Progress, challenges, and translation to the clinic," Journal of Musculoskeletal and Neuronal Interactions, vol. 11, no. 2, pp. 163-173, 2011.
 V. Kishore, W. Bullock, X. Sun, W. S. Van Dyke, and O. Akkus, "Tenogenic differentiation of human MSCs induced by the topography of electrochemically aligned collagen threads," Biomaterials, vol. 33, no. 7, pp. 2137-2144, 2012.
 A. Sensini, C. Gualandi, L. Cristofolini et al., "Biofabrication of bundles of poly(lactic acid)-collagen blends mimicking the fascicles of the human Achille tendon," Biofabrication, vol. 9, no. 1, Article ID 015025, 2017.
 M. R. Ladd, S. J. Lee, J. D. Stitzel, A. Atala, and J. J. Yoo, "Coelectrospun dual scaffolding system with potential for muscletendon junction tissue engineering," Biomaterials, vol. 32, no. 6, pp. 1549-1559, 2011.
 S. Deepthi, M. Nivedhitha Sundaram, J. Deepti Kadavan, and R. Jayakumar, "Layered chitosan-collagen hydrogel/aligned PLLA nanofiber construct for flexor tendon regeneration," Carbohydrate Polymers, vol. 153, pp. 492-500, 2016.
 E. C. Green, Y. Zhang, H. Li, and M. L. Minus, "Gel-spinning of mimetic collagen and collagen/nano-carbon fibers: Understanding multi-scale influences on molecular ordering and fibril alignment," Journal of the Mechanical Behavior of Biomedical Materials, vol. 65, pp. 552-564, 2017.
 R. De Santis, F. Sarracino, F. Mollica, P. A. Netti, L. Ambrosio, and L. Nicolais, "Continuous fibre reinforced polymers as connective tissue replacement," Composites Science and Technology, vol. 64, no. 6, pp. 861-871, 2004.
 G. A. Johnson, D. M. Tramaglini, R. E. Levine, K. Ohno, N.-Y. Choi, and S. L.-Y. Woo, "Tensile and viscoelastic properties of human patellar tendon," Journal of Orthopaedic Research, vol. 12, no. 6, pp. 796-803, 1994.
 J. Peltonen, N. J. Cronin, J. Avela, and T. Finni, "In vivo mechanical response of human Achilles tendon to a single bout of hopping exercise," Journal of Experimental Biology, vol. 213, no. 8, pp. 1259-1265, 2010.
 R. B. Svensson, P. Hansen, T. Hassenkam et al., "Mechanical properties of human patellar tendon at the hierarchical levels of tendon and fibril," Journal of Applied Physiology, vol. 112, no. 3, pp. 419-426, 2012.
 K. Gelse, E. Poschl, and T. Aigner, "Collagens--structure, function, and biosynthesis," Advanced Drug Delivery Reviews, vol. 55, no. 12, pp. 1531-1546, 2003.
 G. Y. F. Ng, "Ligament injury and repair: Current concepts," Hong Kong Physiotherapy Journal, vol. 20, pp. 22-29, 2002.
 Y. A. Kharaz, S. Tew, E. Canty-Laird, and E. Comerford, "A comparison of the extracellular matrix composition of tendon/ligament tissue and tissue engineered tendon and ligament construct," Osteoarthritis and Cartilage, vol. 22, p. S313, 2014.
 J. E. Carpenter, S. Thomopoulos, and L. J. Soslowsky, "Animal models of tendon and ligament injuries for tissue engineering applications," Clinical Orthopaedics and Related Research, no. 367, pp. S296-S311, 1999.
Feras Alshomer (iD), (1,2) Camilo Chaves, (1,3) and Deepak M. Kalaskar (1,4)
(1) UCL Centre for Nanotechnology and Regenerative Medicine, Division of Surgery & Interventional Science, University College London, London NW3 2PF, UK
(2) King Khalid University Hospital Surgery Department 37, Plastic and Reconstructive Surgery Section, Riyadh 11472, Saudi Arabia 3Universite Paris Sud, 63 Rue Gabriel Peri, 94270 Le Kremlin-Bicetre, France
(4) Institute of Orthopaedics and Musculoskeletal Science, Division of Surgery and Interventional Science, University College London, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex HA7 4LP, UK
Correspondence should be addressed to Feras Alshomer; firstname.lastname@example.org
Received 6 May 2018; Revised 6 July 2018; Accepted 26 July 2018; Published 7 August 2018
Academic Editor: Amit Bandyopadhyay
Caption: Figure 1: Complex structural hierarchy of tendon. Unique structural hierarchy in which collagen molecules represent the simplest forming structure of tendon with complex arrangement up to tendon fascicles producing the final tendon tissue.
Caption: Figure 2: Comparison between natural and tissue engineered tendon and ligament constructs. Unique cellular and extracellular matrix composition that is different between the two types of tissues is important for future clinical translation of tendon and ligament research. SOD3, superoxide dismutase; MPa, mega-Pascal; GPa, giga-Pascal.
Table 1: Summary of the literature related to the applications of hybrid biomaterial in tendon tissue engineering. * indicates that approximate numbers were extracted from supplied figures since no exact reference values are mentioned in the text. PDS: poly- dioxanone; SCX, scleraxis; TGF[beta], transforming growth factor beta; hECS-MSCs, mesenchymal stem cells derived from human embryonic stem cells; rhSDFl, recombinant human sto PGA, poly-(lactide-co-glycolide); PCL, poly-caprolactone; bFGF, basic fibroblast growth factor. COMPOSITE/HYBRID MODEL SCAFFOLD PROPERTIES PGA/PLA composite. In vitro After implantation  (ADSCs) in Achilles In vivo tendon, (rabbit) Tensile strength: 4.88 [+ or -] 8.07 MPa No report of other mechanical properties. P (LLA-CL)/ In vitro Young's modulus * Collagen I.  (Tenocytes) Nonseeded about 2.2 MPa. Cell seeded about 3 MPa. Tensile strength * Nonseeded about 3 MPa. Cell seeded about 4.5 MPa. P (LLA-CL)/ In vitro Mechanical stress: Collagen I (TDSCs) Dynamic group was nanoyarn.  59.58 [+ or -] In vivo 7.81 MPa (mouse) Static group was 43.18 [+ or -] 6.58 MPa Control group was 32.43 [+ or -] 5.27% MPa Young's modulus: Dynamic group was 51.99 [+ or -] 7.16 MPa Static group was 34.76 [+ or -] 4.75 MPa. Control group was 23.30 [+ or -] 3.83 MPa PLA / Collagen-I In Vitro Composite electrospun (Tenocytes) scaffolds were bundles  made from blends containing PLA/ Coll-75/25 (w/w). Young's modulus was 98.6 [+ or -] 12.4 MPa Maximum stress was 14.2 [+ or -] 0.7 MPa PLA-graphene In vitro Young's modulus nanoplatelets (fibroblast) PLA control: (GNP) and 3.99 [+ or -] 0.42 PLA-carboxyl- In vivo GPa functionalized carbon (mouse) PLA/ CNT-COOH: nanotubes 4.86 [+ or -] 0.47 (CNT-COOH) GPa [28, 29] PLA/ GNP: 4.92 [+ or -] 0.15 GPa Tensile strength PLA control: 59.90 [+ or -] 4.93 MPa PLA/ CNT-COOH: 72.22 [+ or -] 1.52 MPa PLA/ GNP: 58.56 [+ or -] 3.99 MPa PCL/ collagen- In vitro Tensile strength PLLA/collagen (myoblasts, was 0.5058  fibroblast) [+ or -] 0.2130 MPa Maximum strain was 18.49% [+ or -] 8.210 Young's modulus was 7.339 [+ or -] 2.131 MPa Aligned PLLA In vitro Maximum Force to nanofiber/Layered (Tenocytes) break For uncoated chitosan-collagen 2 and hydrogel/ 3 layers scaffold: Alginate outer 7.89 [+ or -] 1.5N coating.  and 7.45 [+ or -] 0.3N, For gel coated 2 and 3 layers scaffolds: 4.76 [+ or -] 0.23N and 6.49 [+ or -] 0.09N. No report of other mechanical properties. Electrospun In vivo Before collagen I (rabbit) implantation: nanofiber/ Maximum load was collagen 28.33 [+ or -] microfiber 2.19 N.  Maximum stress was 2.69 [+ or -] 0.47 MPa Maximum strain was 61.34 [+ or -] 4.71 % Young's modulus was 43.81 [+ or -] 4.19 KPa. 60 days after implantation to Achilles tendon: Maximum load was about 63.72 N. Maximum stress was about 9.84 N/mm. Maximum strain was about 16.35% Young's modulus was about 0.62 N/mm. Electrospun In vivo After 60 days of collagen I (rabbit) implantation to nanofiber/ Achilles tendon: collagen microfiber/ Maximum load * was PDS sheets.  about 74.02 N Maximum stress * was about 11.37 MPa Young's modulus * was about 0.754 MPa Core-shell In vitro Tensilemodulus for Collagen type I/ (Tenocytes) dry membranes was Glycosaminoglycan. about 636 [+ or -]  47MPa to 693 [+ or -] 20 MPa Tensilemodulus for hydratedmembranes was 30MPa. Tensilemodulus for dry aligned core scaffold ranges from 833 [+ or -] 236 to 829 [+ or -] 165 KPa Collagen-I/ -- Mechanical Nanocarbon assessment in wet fibers  condition Young's modulus was 840 [+ or -] 140 MPa Tensile strength was 70 [+ or -] 8MPa Collagen type I/ In vitro Maximum stress was Resilin  (Fibroblasts) 34.63 [+ or -] 9.75 MPa Maximum strain was 0.21 [+ or -] 0.04 MPa Young's modulus was 49.48 [+ or -] 10.71MPa poly-[epsilon]- In vitro (ADSCs) Maximum load was about 0.25 N. caprolactone No report of other mechanical (PCL) and properties. methacrylated gelatin (mGLT)  Sericin extracted In vitro 4 weeks after implantation to knitted (hESC-MSCs) Achilles tendon silk/cross-linked In vivo (mouse) of cell-seeded scaffolds: collagen type I Maximum load was microsponges  65.24 [+ or -] 9.58 N Maximum stress was 6.72 [+ or -] 0.90 MPa Stiffness was 28.26 [+ or -] 2.95 N/mm Young's modulus was 34.91 [+ or -] 5.08 MPa Sericin extracted In vitro 4 weeks after implantation in knitted silk/ (fibroblast) Achilles tendon: cross-linked In vivo (rat) collagen type I Maximum load was microsponges/ 68.5 [+ or -] 18 N rhSDF-1 alpha  Maximum stress was 7.02 [+ or -] 1.7 MPa Stiffness was 39.0 [+ or -] 6.6 N/mm Young's modulus was 45.3 [+ or -] 10.4 MPa Sericin extracted In vitro 4 weeks after implantation: knittedsilk/cross- (hESC-MSCs) Young's modulus was linked collagen In vivo (mouse) 60.63 [+ or -] 17.6 MPa type I microsponges/ Maximum stress SCX engineered was 8.73 [+ or -] 2.15 MPa cells  8 weeks after implantation: Young's modulus was 71.3 [+ or -] 12.4 MPa Maximum stress was 10.1 [+ or -] 2.2MPa Knitted silk In vitro Maximum stress was coated with (Fibroblast) 13.5 [+ or -] 1.5 MPa electrospun collagen-I / Young's modulus was polyurethane (PU) 21.7 [+ or -] 4MPa nanofibers  Silk coated with In vitro Maximum load Polycaprolactone (Fibroblast) 97.6 [+ or -] 11.4 N for (PCL) or silk fbroin/P3HB Poly(3- hydroxybutyrate) 110.5 [+ or -] 6.6 N for (P3HB) silk fibroin/PCL nanofibers  No report of other mechanical properties. Degummed In vitro (MSCs) Maximum load for dynamic Silk-fibroin culture condition meshes/aligned Aligned scaffold Silk-fibroin 144.44 [+ or -] 5.03  N (7 days) 172.08 [+ or -] 6.28 N (14 days) Random Scaffold 122.35 [+ or -] 3.67 N (7 days) 138.67 [+ or -] 9.22 N (14 days) Stiffness Aligned scaffold 24.33 [+ or -] 1.40 N/mm (7 days) 26.93 [+ or -] 2.40 N/mm (14 days) Random Scaffold 17.48 [+ or -] 0.93 N/mm (7 days) 23.07 [+ or -] 2.54 N/mm (14 days) No report of other mechanical properties. Knitted PLGA-PLLA In vitro (BMSCs) Maximum load / coating Uncoated 68.4 [+ or -] 5.37 with N. (1) PCL. (2) PLGA PCL coated 63.1 [+ or -] 4.52 nanofiber. Type I N. collagen  PLGA coated 56.3 [+ or -] 6.61 N. Collagen coated 59.5 [+ or -] 8.3 N. Stiffness Uncoated 9.1 [+ or -] 2.38 N/mm. PCL coated 4.3 [+ or -] 0.91 N/mm. PLGA coated 5.8 [+ or -] 0.70 N/mm. Collagen coated 5.7 [+ or -] 0.48 N/mm. No report of other mechanical properties. PLGA nanofiber/ In vitro (BMSCs) Maximum load of unseeded Silk microfiber scaffolds  75.3 [+ or -] 4.79 N on day 0, and 61.5 [+ or -] 3.43 N on day 21 Maximum load of rolled seeded scaffolds 68.2 [+ or -] 6.72 N on day 21 Stiffness of unseeded scaffolds 4.8 [+ or /] 0.52 N/mm on day 0, and 5.9 [+ or /] 0.54 N/ mm on day 21 Stiffness of rolled seeded scaffolds 5.5 [+ or -] 0.30 N/mm on day 21 No report of other mechanical properties. PLGA nanofiber/ In vitro 3 weeks after culture of bFGF / Silk (mesenchymal rolled scaffolds: microfiber  progenitor cell) Maximum load Unseeded scaffolds * were about 61.5 N Seeded bFGF-free scaffolds * were about 68.2 N Seeded bFGF scaffolds * were about 82.7 N Stiffness Unseeded scaffolds * were about 5.92 N/mm Seeded bFGF/free scaffolds * were about 5.53 N/mm Seeded bFGF scaffolds * were about 6.97 N/mm Alginate / In vitro Tensile strength was 235.2 0.1% chitosan  (fibroblast) [+ or -] 8.5 MPa Maximum strain was 12.3 [+ or -] 0.3 % Chitosan / In vitro (i) In vitro: 0.1% hyaluronic (fibroblast) Tensile strength: acid In vivo (rat) Before seeding was 213.3  [+ or -] 10 MPa 2 hrs after seeding was 60 [+ or -] 6.7MPa 14 days after seeding was 66.7 [+ or -] 6.8 MPa 28 days after seeding was 65.1 [+ or -] 6.6 MPa Maximum strain: Before seeding was 3.2 [+ or -] 0.6 % (ii) In vivo tendon model: Tangent modulus for cell- seeded scaffold: 4 weeks after implantation: about 58 [+ or -] MPa 12 weeks after implantation: about 85 [+ or -] MPa In vivo ligament model: Maximum load for cell-seeded scaffold: 12 weeks after implantation: about 110 [+ or -] 10 N COMPOSITE/HYBRID MODEL CELL/TISSUE INTEGRATION PGA/PLA composite. In vitro (i) Grossly, the  (ADSCs) implanted cell- In vivo seeded scaffold (rabbit) was integrated with the native tissue interference, with a smooth surface cord-like shape with less noticeable remaining material after 45 weeks. (ii) Tissue adhesions, described grossly to be less compared to control. (iii) Parallel and more mature collagen fibers and longitudinally aligned cells are presents than control. P (LLA-CL)/ In vitro (i) Significantly Collagen I.  (Tenocytes) higher cell proliferation in the nanoyarn scaffold compared to other scaffolds and control. (ii) SEM showed spindle-shaped cell in both nanoyarn and aligned nanofiber scaffold, while polygonal and random pattern cells are found in the random oriented fibers. (iii) Expression of tendon specific ECM (type I collagen, type III collagen, decorin, tenascin-C, and biglycan) was significantly higher at 14 days in the nanoyarn group. P (LLA-CL)/ In vitro TDSCs were used in Collagen I (TDSCs) scaffold seeding nanoyarn.  with both dynamic In vivo and static culture (mouse) conditions. In vitro: (i) TDSCs showed elongated fibroblast-like morphology with a significant increase in cell count in dynamic group at 14 days. (ii) More cell infiltration and dense matrix in dynamic group. (iii) PCR confirmed Tendon related mRNA expression more in dynamic group. (iv) Western blotting showed significant increase in the protein expression levels of Collagens I and III, and tenascin- C in the dynamic group. In-vivo: (i) Significantly lower number of cells at 12 weeks with greater matrix deposition and longitudinal spindle-shaped cells in dynamic group compared to others. (ii) Collagen content was highest in dynamic group reaching 77.76 [+ or -] 6.82% of normal rabbit patellar tendon (174.31 [+ or -] 13.89 [micro]g/mg). (iii) Collagen I expression was Significantly higher in dynamic group. PLA / Collagen-I In Vitro (i) Seeded electrospun (Tenocytes) Tenocytes shown to bundles  exhibit good cell adhesion profile and more elongated morphology that was better over PLA/Coll-50/50 blends than other. PLA-graphene In vitro (i) Both produced nanoplatelets (fibroblast) scaffolds (GNP) and supported PLA-carboxyl- In vivo fibroblasts functionalized metabolic activity carbon (mouse) and proliferation nanotubes till final (CNT-COOH) assessment point [28, 29] (72 hrs). (ii) In vivo assessment showed lack of any local or systemic inflammatory response using N- acetylglucosaminidase (NAG) and nitric oxide (NO) serum levels. (iii) No associated hepatotoxicity in histologic assessment. (iv) Histologic assessment of explanted scaffold showed formation of thin capsule around the implant with homogenous granulation tissue. PCL/ collagen- In vitro (i) Statistically PLLA/collagen (myoblasts, higher viability  fibroblast) of both myoblast and fibroblasts in all regions of the scaffold. (ii) Scaffold could support the formation of myotubes that is essential for normal muscle-ten don junction formation. Aligned PLLA In vitro (i) Alginate nanofiber/Layered (Tenocytes) coating was chitosan-collagen associated with hydrogel/ significantly less Alginate outer attached proteins coating.  than control. (ii) Both coated and uncoated scaffold maintain 50% of their substance after incubation with PBS containing 104 units/ml lysozyme solution. (iii) Alamar blue and DNA concentration assessment showed high cellular viability, metabolic activity, and proliferation up to 7 days after seeding. (iv) Seeded scaffolds were shown to support cellular alignment. Electrospun In vivo In vitro: collagen I (rabbit) (i) Significantly nanofiber/ higher cell collagen viability in the microfiber aligned hybrid  scaffold compared to others. (ii) SEM and immunofuorescence proven superior alignment of fibroblasts together with cell proliferation with close cell-to- cell contact in the aligned hybrid scaffold compared to others. In vivo: (i) Significant increase in the number, density, and alignment of the collagen deposition with mature elastic fibers. (ii) Significant increase in the number and maturity of tenoblasts and tenocytes. (iii) Significantly lower peritendinous adhesions, muscle fibrosis, and atrophy and inflammatory cells found in the treated tendons compared to controls. Electrospun In vivo (i) Significantly higher collagen I (rabbit) fibrillogenesis after PDS nanofiber/ treatment. collagen microfiber/ (ii) Significantly PDS sheets.  higher collagen fibrils were found in the PDS treated scaffolds compared to the regular one. (iii) Significant increase in the load to failure and load to yield point with PDS treatment. (iv) Significantly improved peritendinous adhesions, muscle fibrosis, and atrophy scores that are comparable in the PDS treated and nontreated collagen scaffolds. Core-shell In vitro (i) Significant Collagen type I/ (Tenocytes) increase in the Glycosaminoglycan. number of cells at  day 1 after seeding in the core-shell composite compared to core alone scaffolds. (ii) Higher metabolic activity observed at day 7 in the core alone scaffold that is statistically significant. (iii) No significant difference in the metabolic activity and cell number between the two groups at 14-day period. Collagen-I/ -- (i) No cell work nanocarbon fibers was presented.  Collagen type I/ In vitro (i) Human adult fibroblasts Resilin  (Fibroblasts) were used in the assessment process. (ii)Te authors showed that addition of resilin and the use of poly(ethylene glycol) either tetrasuccinimidyl glutarate did compromise the cellular activity. (iii) Te scaffold produced managed to support cellular proliferation and 100% cellular alignment after 7 days of seeding compared to 80% in collagen control. poly-[epsilon]- In vitro (ADSCs) (i) Tenogenic differentiation caprolactone was induced through (PCL) and differentiation medium having methacrylated DMEM, 2% FBS, P-S, and 10 ng- gelatin (mGLT) ml TGF-[beta]3 for 7 days  after seeding. (ii) Seeded constructs were shown to exhibit elongated morphology as well as expression of tenogenicmarkers (scleraxis and Tenascin-C). (iii) Stacked scaffold was shown to have adequate porosity for cell diffusion and differentiation. Sericin extracted In vitro In vitro: knitted (hESC-MSCs) (i) Good cell attachment, silk/cross-linked In vivo (mouse) proliferation, and spreading collagen type I at 14 days' period. microsponges  (ii) Scx., collagen I, and collagen III expression were significantly higher in dynamic group than the control. In vivo assessment after 4 weeks of implantation: (i) Grossly, well-integrated construct with native tendons. (ii) Viable cells are presents showing spindle- shaped morphology. (iii) Significantly higher collagen I, III, V[alpha]1, V[alpha]2, and TGF[beta]1 in cell-seeded scaffold compared to cell free scaffold. (iv) Neocollagen was replacing exogenous one with more content, and mature morphology in cell-seeded scaffold compared to cell free scaffold. Sericin extracted In vitro In vivo assessment after 4 knitted silk/ (fibroblast) weeks of implantation: cross-linked In vivo (rat) collagen type I (i) More fibroblasts-like microsponges/ cells and less inflammatory rhSDF-1 alpha  cells are found early after implantation (4 days, 1 week). (ii) More organized continuous collagen fibers are found with a higher concentration of collagen type I. (iii) Good vascular components with less inflammatory cells are present. (iv) Significantly higher expression of Collagens I and III, decorin in the SDF-1 scaffolds at all assessment periods. (v) Large fibrils of Achilles tendons formed in the SDF-1 scaffolds (41.6 [+ or -] 5.5 nm) compared to control (37.1 [+ or -] 2.9 nm). Sericin extracted In vitro In vitro: knittedsilk/cross- (hESC-MSCs) (i) SCX treatment increases linked collagen In vivo (mouse) collagen I expression with type I enhanced cell-sheet microsponges/ formation. SCX engineered cells  (ii) Decreased capacity of adipogenic, chondrogenic, and osteogenic differentiation of the cells with more tenogenic differentiation. In vivo: (i) Good proliferation and early matrix deposition in the SCX cells compared to control. (ii) Increased Collagen Ia1, Ia2, and tendon related transcription factor Eya2 in SCX cells compared to control. (iii) More fibroblast-like spindle-shaped cells and fewer immunogenic cell infiltrates in the SCX cells group. (iv) Higher expression of biglycan in the SCX cells group, indicating more mature endogenous collagen. Knitted silk In vitro (i) Human fibroblasts were coated with (Fibroblast) seeded on composite scaffold electrospun to test for viability. collagen-I / polyurethane (PU) (ii) Assessment was made nanofibers  through Alamar Blue assay and showed that samples with higher collagen content had higher cellular viability profile (COL75/PU25) than other groups. Silk coated with In vitro (i) Human fibroblasts were Polycaprolactone (Fibroblast) seeded on composite scaffold (PCL) or and showed good cellular Poly(3- viability and no toxicity hydroxybutyrate) (assessment for 3 days). (P3HB) nanofibers  Degummed In vitro (MSCs) (i) Highly significant cell Silk-fibroin viability in the aligned meshes/aligned scaffold compared to the Silk-fibroin  random one at both dynamic and static conditions. (ii) Consistent cellular proliferation in both aligned (dynamic and static) and dynamic random scaffold. (iii) Higher collagen deposition in the dynamic aligned scaffold compared to the static one and the random scaffold groups. (iv) Dynamic culture improved the histological assessment of both aligned and random scaffold with more cell elongation and matrix deposition. (v) Higher expression level of collagen I, tenascin-C, and tenomodulin in the aligned dynamic scaffolds compared to others. Knitted PLGA-PLLA In vitro (BMSCs) (i) Efficient cell seeding on / coating PLGA nanofiber coated and with collagen-coated scaffolds. (1) PCL. (80-89% and 61-69%, (2) PLGA nanofiber. respectively). Type I collagen  (ii) Significantly higher cell proliferation between 2nd and 7th culture days of PLGA nanofiber coated knitted PLGA scaffolds. PLGA nanofiber/ In vitro (BMSCs) (i) Dual surface seeded Silk microfiber scaffolds showed significantly  higher cell proliferation rates compared to single surface seeding. (ii) Increased cell proliferation between 14 days and 21 days after culture. (iii) Rolled-up scaffolds had nonsignificantly lower cell proliferation rates. PLGA nanofiber/ In vitro (i) Significantly higher cell bFGF / Silk (mesenchymal viability in the bFGF scaffolds microfiber  progenitor cell) compared to bFGF-free scaffolds. (ii) Significantly higher collagens I and III, fibronectin, and biglycan 14 days after culture in the bFGF scaffolds compared to bFGF free scaffolds. (iii) Significantly higher collagen content in the bFGF scaffolds compared to bFGF free scaffolds by 3rd week after culture. Alginate / In vitro (i) Significantly lower number 0.1% chitosan  (fibroblast) of unattached cells in alginate--chitosan group compared to polyglactin and alginate alone. (ii) Fibroblasts were spread on the polymer fibers. (iii) Prominent collagen type I production 14 days after culture was more on the scaffold surface by immune staining with no clear visualization of both types II and III collagen. Chitosan / In vitro In vitro up to 28 days after 0.1% hyaluronic (fibroblast) cell seeding: acid In vivo (rat)  (i) Gross observation of ECM production by lightmicroscopy. (ii) Prominent collagen type I production 14 days after culture more on the scaffold surface. In vivo tendon model: (i) Type I collagen is seen only in cell-seeded scaffold. In vivo ligament model: None.
|Printer friendly Cite/link Email Feedback|
|Author:||Alshomer, Feras; Chaves, Camilo; Kalaskar, Deepak M.|
|Publication:||Journal of Materials|
|Date:||Jan 1, 2018|
|Previous Article:||Modification of Aluminium 6063 Microstructure by Adding Boron and Titanium to Improve the Thermal Conductivity.|